ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Lidds AB's annualized net income for the quarter that ended in Sep. 2025 was €-0.32 Mil. Lidds AB's average Total Stockholders Equity over the quarter that ended in Sep. 2025 was €0.17 Mil. Therefore, Lidds AB's annualized ROE % for the quarter that ended in Sep. 2025 was -194.59%.
The historical rank and industry rank for Lidds AB's ROE % or its related term are showing as below:
FRA:5LD'
s ROE % Range Over the Past 10 Years
Min: -274.93 Med: -87.04 Max: -6.25
Current: -107.64
During the past 13 years, Lidds AB's highest ROE % was -6.25%. The lowest was -274.93%. And the median was -87.04%.
FRA:5LD's ROE % is not ranked
in the Biotechnology industry.
Industry Median: -38.26
vs FRA:5LD: -107.64
Lidds AB (FRA:5LD) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Sep. 2025) net income data. The Revenue data used here is four times the quarterly (Sep. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Lidds AB ROE % Related Terms
Lidds AB ROE % Historical Data
* Premium members only.
The historical data trend for Lidds AB's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Lidds AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lidds AB ROE % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lidds AB's ROE % distribution charts can be found below:
* The bar in red indicates where Lidds AB's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Sep. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Lidds AB (FRA:5LD) has a ROE % of -194.59% as of Sep. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Lidds AB and its competitors.
Is Lidds AB's ROE % too high?
Lidds AB's current ROE % is -194.59%.
How does Lidds AB's ROE % compare to VRTX and REGN?
Lidds AB's ROE % of -194.59% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Biotechnology company?
A good ROE % depends on the Biotechnology industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Lidds AB and its competitors. Lidds AB's current ROE % is -194.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lidds AB stock overvalued right now?
Lidds AB (FRA:5LD) has a current ROE % of -194.59%. The current ROE % is -194.59%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Lidds AB (FRA:5LD), the current ROE % is -194.59% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lidds AB is a Sweden-based drug delivery company focused on its proprietary NanoZolid technology platform. The NanoZolid system is used to formulate drugs for local administration with controlled and sustained release over extended periods. The company offers this technology to partners and is also developing its own pipeline of drug candidates, prominently in oncology, where the platform is used to enable localized and sustained drug delivery. It has a pipeline with several projects in clinical development, both in early- and late-stage clinical phases, and projects about to enter clinical development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LD has been successfully added to your 